zepbound vs retatrutide Retatrutide: The Unapproved Drug America Already Takes Zepbound vs Retatrutide: FDA Indications,

LY3437943 (retatrutide), a triple agonist at GIP, GLP-1, and glucagon receptors

Semaglutide has a 1-week half life, meaning your body eliminates half the medication every 7 days

Exposure to High-Dose Liraglutide in a Pregnant Woman With Obesity

At the same time, adequate hydration helps support several of the bodys normal processes, including: Digestive comfort Regular bowel function Energy levels Healthy fluid balance Kidney function For these reasons, many healthcare professionals recommend paying a little more attention to water intake when starting a GLP-1 medication

Medications that target GLP-1 and GIP hormones have become an exciting advancement in the treatment of weight management and metabolic health

The study found that patients on GLP-1 drugs had significantly less weight loss than those who had bariatric surgery, but a nearly identical reduction in cancer risk